A pan-cancer study indicated that KAT2A was found to cooperate with E2F1 and be recruited by E2F1 to the UBE2C promoter for elevating the expression of UBE2C by increasing the acetylation level of H3K9 to promote cell proliferation and the migration of cancer cells [54]. The gene discussed is KAT2A; the disease is cancer.